Japan Medical Dynamic Marketing INC
Japan Medical Dynamic Marketing, INC. develops, manufactures, imports, and sells medical devices in Japan and the United States. The company provides trauma devices, including nails, screws, plates, and other products surgically implanted in the fracture site; joint prostheses, which replaces natural joints and restores functions damaged or lost due to disease or injury; spinal fixation devices t… Read more
Japan Medical Dynamic Marketing INC (JMD) - Net Assets
Latest net assets as of September 2025: €24.34 Billion EUR
Based on the latest financial reports, Japan Medical Dynamic Marketing INC (JMD) has net assets worth €24.34 Billion EUR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€32.68 Billion) and total liabilities (€8.34 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €24.34 Billion |
| % of Total Assets | 74.47% |
| Annual Growth Rate | 7.6% |
| 5-Year Change | 32.21% |
| 10-Year Change | 118.39% |
| Growth Volatility | 5.66 |
Japan Medical Dynamic Marketing INC - Net Assets Trend (2014–2025)
This chart illustrates how Japan Medical Dynamic Marketing INC's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Japan Medical Dynamic Marketing INC (2014–2025)
The table below shows the annual net assets of Japan Medical Dynamic Marketing INC from 2014 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | €24.74 Billion | -3.37% |
| 2024-03-31 | €25.60 Billion | +9.92% |
| 2023-03-31 | €23.29 Billion | +8.38% |
| 2022-03-31 | €21.49 Billion | +14.84% |
| 2021-03-31 | €18.71 Billion | +10.12% |
| 2020-03-31 | €16.99 Billion | +11.55% |
| 2019-03-31 | €15.23 Billion | +14.85% |
| 2018-03-31 | €13.26 Billion | +7.93% |
| 2017-03-31 | €12.29 Billion | +8.47% |
| 2016-03-31 | €11.33 Billion | +4.39% |
| 2015-03-31 | €10.85 Billion | -1.79% |
| 2014-03-31 | €11.05 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Japan Medical Dynamic Marketing INC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 200.1% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €15.75 Billion | 63.83% |
| Other Components | €8.93 Billion | 36.17% |
| Total Equity | €24.68 Billion | 100.00% |
Japan Medical Dynamic Marketing INC Competitors by Market Cap
The table below lists competitors of Japan Medical Dynamic Marketing INC ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
DANIEL THWAITES LS-25
F:7KW
|
$43.47 Million |
|
Intech Biopharm Ltd
TWO:6461
|
$43.47 Million |
|
REFINE Co. Ltd.
KQ:377450
|
$43.49 Million |
|
Binh Duong Trade and Development JSC
VN:TDC
|
$43.49 Million |
|
Mega Or
TA:MGOR
|
$43.45 Million |
|
Remed Co.Ltd
KQ:302550
|
$43.44 Million |
|
GBM Resources Ltd
AU:GBZ
|
$43.44 Million |
|
Gunnison Copper Corp
OTCQB:GCUMF
|
$43.44 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Japan Medical Dynamic Marketing INC's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 25,511,321,000 to 24,679,259,000, a change of -832,062,000 (-3.3%).
- Net loss of 461,798,000 reduced equity.
- Dividend payments of 371,092,000 reduced retained earnings.
- Share repurchases of 10,732,000 reduced equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-461.80 Million | -1.87% |
| Dividends Paid | €371.09 Million | -1.5% |
| Share Repurchases | €10.73 Million | -0.04% |
| Other Changes | €11.56 Million | +0.05% |
| Total Change | €- | -3.26% |
Book Value vs Market Value Analysis
This analysis compares Japan Medical Dynamic Marketing INC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-03-31 | €464.72 | €2.90 | x |
| 2018-03-31 | €501.24 | €2.90 | x |
| 2019-03-31 | €575.30 | €2.90 | x |
| 2020-03-31 | €641.61 | €2.90 | x |
| 2021-03-31 | €706.07 | €2.90 | x |
| 2022-03-31 | €810.59 | €2.90 | x |
| 2023-03-31 | €880.64 | €2.90 | x |
| 2024-03-31 | €968.74 | €2.90 | x |
| 2025-03-31 | €937.15 | €2.90 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Japan Medical Dynamic Marketing INC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -1.87%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -1.84%
- • Asset Turnover: 0.75x
- • Equity Multiplier: 1.36x
- Recent ROE (-1.87%) is below the historical average (6.67%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 2.59% | 3.02% | 0.49x | 1.76x | €-819.10 Million |
| 2015 | -3.61% | -3.30% | 0.59x | 1.86x | €-1.48 Billion |
| 2016 | 7.07% | 6.14% | 0.65x | 1.78x | €-331.60 Million |
| 2017 | 9.22% | 8.30% | 0.63x | 1.76x | €-96.09 Million |
| 2018 | 10.77% | 9.63% | 0.71x | 1.58x | €102.12 Million |
| 2019 | 13.07% | 11.86% | 0.71x | 1.55x | €465.70 Million |
| 2020 | 12.79% | 11.97% | 0.73x | 1.47x | €472.12 Million |
| 2021 | 8.94% | 9.94% | 0.66x | 1.35x | €-198.36 Million |
| 2022 | 9.99% | 11.13% | 0.70x | 1.28x | €-2.95 Million |
| 2023 | 6.15% | 6.68% | 0.72x | 1.27x | €-892.44 Million |
| 2024 | 4.98% | 5.49% | 0.74x | 1.23x | €-1.28 Billion |
| 2025 | -1.87% | -1.84% | 0.75x | 1.36x | €-2.93 Billion |
Industry Comparison
This section compares Japan Medical Dynamic Marketing INC's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Japan Medical Dynamic Marketing INC (JMD) | €24.34 Billion | 2.59% | 0.34x | $43.45 Million |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.23 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $44.77 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.65 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $610.05 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.55 Million |